To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
Since it was established, the CEA has supported and contributed the companies’ effort for innovation by putting its expertise and technologies at their service.
In the Suppliers area, you will find the CEA’s procurement policy and the possibility to consult and respond to current calls for tenders.
The CEA is one of Europe’s largest major research bodies. It is active in the fields of low carbon energies, information and healthcare technologies, defence and security. The Companies area is intended for firms interested in R&D collaboration with the CEA as well as those seeking to offer their services to the CEA.
ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it has signed an exclusive license with CEA to develop and commercialize the investigational WIMAGINE BCI designed by Clinatec as part of its investigational ARC-BCI System to restore thought-driven movement and function of the human body.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.